BCI Marketplace
Transcranial Magnetic Stimulation trials

Medial-prefrontal Enhancement During Schizophrenia Systems Imaging

RecruitingNCT04807530Phase: NAStarted 2020-11-12

Summary

This randomized controlled trial in healthy controls (HC) and patients with schizophrenia (SZ) aims to examine 1) the underlying cognitive and neural cause of self-agency deficits in SZ; 2) the responsiveness to a novel navigated repetitive transcranial magnetic stimulation (nrTMS) target in the medial/superior prefrontal cortex (mPFC); and 3) how modulation of mPFC activity impacts the larger self-agency network to mediate changes in self-agency judgments. Our overall hypothesis is that increas

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
64 Years

Inclusion Criteria: All Subjects: * Good general physical health * English is first language * No neurological disorder * Meets MRI criteria * No current alcohol or substance use disorder Schizophrenia participants: * Schizophrenia diagnosis of any illness duration, * Clinical stability, defined

Locations

UCSF
San Francisco, California, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →